Surendra Shenoy

Summary

Affiliation: Washington University School of Medicine
Country: USA

Publications

  1. ncbi Economic impact of the beneficial effect of changing vascular anastomotic technique in hemodialysis access
    Surendra Shenoy
    Washington University School of Medicine, St Louis, MO 63110, USA
    Vasc Endovascular Surg 39:437-43. 2005
  2. ncbi A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients
    Surendra Shenoy
    Department of Medicine, Washington University, Barnes Jewish Hospital, St Louis, MO 63110, USA
    Liver Transpl 14:173-80. 2008
  3. ncbi Sirolimus conversion in liver transplant recipients with renal dysfunction: a prospective, randomized, single-center trial
    Surendra Shenoy
    The Department of Surgery, Washington University, St Louis, MO 63110, USA
    Transplantation 83:1389-92. 2007
  4. ncbi A multicenter study of permanent hemodialysis access patency: beneficial effect of clipped vascular anastomotic technique
    Surendra Shenoy
    Washington University School of Medicine, One Barnes Hospital Plaza, Suite 6107 Queeny Tower, St Louis, MO 63110, USA
    J Vasc Surg 38:229-35. 2003
  5. ncbi Cyclosporine minimization and cost reduction in renal transplant recipients receiving a C2-monitored, cyclosporine-based quadruple immunosuppressive regimen
    Karen L Hardinger
    Department of Pharmacy, Barnes-Jewish Hospital, Washington University, One Barnes-Jewish Hospital Plaza, St. Louis, MO 63110, USA
    Transplantation 78:1198-203. 2004
  6. ncbi Donor graft steatosis influences immunity to hepatitis C virus and allograft outcome after liver transplantation
    Vijay Subramanian
    Department of Surgery, Washington University, St Louis, MO 63110, USA
    Transplantation 92:1259-68. 2011
  7. ncbi Short- and long-term outcomes after steatotic liver transplantation
    M B Majella Doyle
    Department of Surgery, Washington University School of Medicine, 660 S Euclid Avenue, St Louis, MO 63110, USA
    Arch Surg 145:653-60. 2010
  8. ncbi Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation
    William C Chapman
    Department of Surgery, Section of Abdominal Transplantation, Washington University School of Medicine, St Louis, MO 63110, USA
    Ann Surg 248:617-25. 2008
  9. ncbi Advanced donor age alone does not affect patient or graft survival after liver transplantation
    Christopher D Anderson
    Department of Surgery, Section of Abdominal Transplantation, Washington University School of Medicine, St Louis, MO, USA
    J Am Coll Surg 207:847-52. 2008
  10. ncbi Liver transplant for hepatitis C virus: effect of using older donor grafts on short- and medium-term survival
    M B Majella Doyle
    Department of Surgery, Section of Abdominal Transplantation, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Arch Surg 143:679-85; discussion 685. 2008

Collaborators

Detail Information

Publications30

  1. ncbi Economic impact of the beneficial effect of changing vascular anastomotic technique in hemodialysis access
    Surendra Shenoy
    Washington University School of Medicine, St Louis, MO 63110, USA
    Vasc Endovascular Surg 39:437-43. 2005
    ..This beneficial effect may be due to the biologic advantages of interrupted, nonpenetrating vascular anastomoses...
  2. ncbi A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients
    Surendra Shenoy
    Department of Medicine, Washington University, Barnes Jewish Hospital, St Louis, MO 63110, USA
    Liver Transpl 14:173-80. 2008
    ..In conclusion, immunosuppression with CsA, monitored by C2 levels, is safe, effective, and economical in liver transplant recipients and provides immunosuppression at least equivalent to that of FK...
  3. ncbi Sirolimus conversion in liver transplant recipients with renal dysfunction: a prospective, randomized, single-center trial
    Surendra Shenoy
    The Department of Surgery, Washington University, St Louis, MO 63110, USA
    Transplantation 83:1389-92. 2007
    ..Although early improvements were observed, withdrawing CNI and replacing it with SRL did not result in a statistically significant improvement in renal function at 12 months of follow-up...
  4. ncbi A multicenter study of permanent hemodialysis access patency: beneficial effect of clipped vascular anastomotic technique
    Surendra Shenoy
    Washington University School of Medicine, One Barnes Hospital Plaza, Suite 6107 Queeny Tower, St Louis, MO 63110, USA
    J Vasc Surg 38:229-35. 2003
    ....
  5. ncbi Cyclosporine minimization and cost reduction in renal transplant recipients receiving a C2-monitored, cyclosporine-based quadruple immunosuppressive regimen
    Karen L Hardinger
    Department of Pharmacy, Barnes-Jewish Hospital, Washington University, One Barnes-Jewish Hospital Plaza, St. Louis, MO 63110, USA
    Transplantation 78:1198-203. 2004
    ..Lower cyclosporine doses were achieved in C2-monitored patients compared with C0-monitored patients, translating into lower immunosuppressive costs...
  6. ncbi Donor graft steatosis influences immunity to hepatitis C virus and allograft outcome after liver transplantation
    Vijay Subramanian
    Department of Surgery, Washington University, St Louis, MO 63110, USA
    Transplantation 92:1259-68. 2011
    ..The aim of this study was to test the hypothesis that allograft steatosis alters immune responses to HCV and self-antigens promoting allograft fibrosis...
  7. ncbi Short- and long-term outcomes after steatotic liver transplantation
    M B Majella Doyle
    Department of Surgery, Washington University School of Medicine, 660 S Euclid Avenue, St Louis, MO 63110, USA
    Arch Surg 145:653-60. 2010
    ..To determine if the use of steatotic grafts adversely affects outcomes in liver transplantation...
  8. ncbi Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation
    William C Chapman
    Department of Surgery, Section of Abdominal Transplantation, Washington University School of Medicine, St Louis, MO 63110, USA
    Ann Surg 248:617-25. 2008
    ....
  9. ncbi Advanced donor age alone does not affect patient or graft survival after liver transplantation
    Christopher D Anderson
    Department of Surgery, Section of Abdominal Transplantation, Washington University School of Medicine, St Louis, MO, USA
    J Am Coll Surg 207:847-52. 2008
    ..We hypothesized that proper selection of donors older than age 60 would not disadvantage recipients in terms of patient and graft survival...
  10. ncbi Liver transplant for hepatitis C virus: effect of using older donor grafts on short- and medium-term survival
    M B Majella Doyle
    Department of Surgery, Section of Abdominal Transplantation, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Arch Surg 143:679-85; discussion 685. 2008
    ..In addition, recent studies suggest that the use of older donors in recipients with HCV is associated with significantly worsened short- and long-term survival...
  11. ncbi Short course induction immunosuppression with thymoglobulin for renal transplant recipients
    Irfan A Agha
    Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA
    Transplantation 73:473-5. 2002
    ..8 days). CONCLUSION: Three-day induction with thymoglobulin is as effective and safe as seven days, decreases initial hospitalization and causes more sustained lymphocyte depletion...
  12. ncbi Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival
    Ankit Bharat
    Department of Surgery, Section of Abdominal Transplantation, Washington University School of Medicine, 660 S, Euclid Avenue, St Louis, MO 63110, USA
    J Am Coll Surg 203:411-20. 2006
    ..LRT substantially downstages the primary tumor and improves longterm survival in patients with advanced disease. Complete tumor necrosis with LRT is associated with excellent longterm recurrence-free survival...
  13. ncbi Five-year follow up of thymoglobulin versus ATGAM induction in adult renal transplantation
    Karen L Hardinger
    Department of Pharmacy, Washington University School of Medicine, St. Louis, MO, USA
    Transplantation 78:136-41. 2004
    ..The prolonged and profound lymphopenia may contribute to the long-term results associated with Thymoglobulin...
  14. ncbi Liver transplantation for hepatocellular carcinoma: long-term results suggest excellent outcomes
    M B Majella Doyle
    Department of Surgery, Section of Abdominal Transplantation, Washington University School of Medicine, St Louis, MO 63110, USA
    J Am Coll Surg 215:19-28; discussion 28-30. 2012
    ..Selected 5-year survival results after liver transplantation for hepatocellular carcinoma (HCC) have been reported to be 70%. Our hypothesis was that liver transplantation is effective for long-term cancer control for HCC...
  15. ncbi Utilization of hepatitis B core antibody-positive donor liver grafts
    Malcolm P MacConmara
    Section of Transplant Surgery, Department of Surgery, Washington University in St Louis, MO 63110, USA
    HPB (Oxford) 14:42-8. 2012
    ..The inclusion of hepatitis B core antibody-positive (HBcAb+) liver donors is a strategy utilized to increase organ availability. This study examined HBcAb+ transplantation practices to identify specific factors influencing outcomes...
  16. ncbi Immune response to extracellular matrix collagen in chronic hepatitis C-induced liver fibrosis
    Brian B Borg
    Department of Medicine, Washington University School of Medicine, St Louis, MO 63110, USA
    Liver Transpl 17:814-23. 2011
    ..Our results demonstrate that in HCV-infected patients, the levels of Abs to ECM Col1, Col2, and Col5 positively correlate with liver fibrosis, which is associated with a predominantly T(h) 2 and T(h) 17 cytokine profile...
  17. ncbi Elevated soluble CD30 characterizes patients with hepatitis C virus-induced liver allograft cirrhosis
    Ankit Bharat
    Department of Surgery, Washington University School of Medicine, St Louis, MO 63110, USA
    Transplantation 84:1704-7. 2007
    ..Further, sCD30 may represent a novel marker for surveillance of hepatic cirrhosis in transplant recipients with chronic HCV infection...
  18. ncbi Prospective, pilot, open-label, short-term study of conversion to leflunomide reverses chronic renal allograft dysfunction
    Karen L Hardinger
    Department of Pharmacy, Barnes Jewish Hospital, Washington University, St Louis, MO, USA
    Am J Transplant 2:867-71. 2002
    ..Mean CyA levels did not change, 146 +/- 72 ng/ mL pre-LEF vs. 132 +/- 51 ng/mL post-LEF, p = NS. Conversion to LEF reversed progression of chronic renal allograft dysfunction with minimal toxicity...
  19. ncbi Liver transplantation for hepatocellular carcinoma: expanding special priority to include stage III disease
    Jeremy Goodman
    Section of Abdominal Transplantation, Department of Surgery, Washington University, St Louis, MO, USA
    Arch Surg 140:459-64; discussion 464. 2005
    ..Consideration should be given to granting exception points to patients with stage III disease...
  20. ncbi Hepatitis C virus mediated changes in miRNA-449a modulates inflammatory biomarker YKL40 through components of the NOTCH signaling pathway
    Nayan J Sarma
    Department of Surgery, Washington University School of Medicine, Saint Louis, MO, USA
    PLoS ONE 7:e50826. 2012
    ....
  21. ncbi A novel technique of vascular anastomosis to prevent juxta-anastomotic stenosis following arteriovenous fistula creation
    Ankit Bharat
    Department of Surgery, Washington University School of Medicine, St Louis, MO, USA
    J Vasc Surg 55:274-80. 2012
    ..We hypothesized that technical modification to alter the outflow vein configuration using the novel piggyback Straight Line Onlay Technique (pSLOT) would prevent JAS and improve AVF maturation...
  22. ncbi Serial measurements of bone density at the lumbar spine do not predict fracture risk after liver transplantation
    Karen L Hardinger
    Department of Pharmacy, Barnes-Jewish Hospital/Washington University School of Medicine, St Louis, MO 63110, USA
    Liver Transpl 9:857-62. 2003
    ..In conclusion, serial measurements of BMD at the lumbar spine do not appear to predict fracture risk; however, data suggest that female sex is the strongest predictor of fracture after liver transplantation...
  23. ncbi A significant role for histocompatibility in human islet transplantation
    T Mohanakumar
    Department of Surgery, Washington University School of Medicine, St Louis, MO 63110, USA
    Transplantation 82:180-7. 2006
    ..The purpose of this study was to determine the role of pretransplant sensitization to human leukocyte antigen (HLA) in islet transplantation...
  24. ncbi Surgical anatomy of upper arm: what is needed for AVF planning
    Surendra Shenoy
    Washington University School of Medicine, Barnes Jewish Hospital, St Louis, MO, USA
    J Vasc Access 10:223-32. 2009
    ..Accordingly, access planning should involve not only a plan for the initial procedure, but include an algorithm to provide an access sequence to support the patient through the entire ESRD life...
  25. ncbi Psychiatric disorders: are they an absolute contraindication to living donation?
    Anthony A Rowley
    Washington University School of Medicine, Department of Psychiatry, 660 S Euclid, St Louis, MO 63110, USA
    Prog Transplant 19:128-31. 2009
    ..Stable individuals, on or off therapy, can be considered fit to donate with expected short- and long-term outcome prognoses similar to those for the general population...
  26. ncbi Innovative surgical approaches to maximize arteriovenous fistula creation
    Surendra Shenoy
    Washington University School of Medicine, Barnes Jewish Hospital, St Louis, MO 63110, USA
    Semin Vasc Surg 20:141-7. 2007
    ..Early radiological interventions and secondary surgical procedures should be electively performed to aid maturation for fistulae that fail to achieve adequate maturation...
  27. ncbi Image of the month. Focal nodular hyperplasia
    Yolanda Y L Yang
    Divisions of Transplant Surgery and Pediatric Gastroenterology, Washington University School of Medicine, St Louis, MO 63110, USA
    Arch Surg 139:113-4. 2004
  28. ncbi The ideal living donor nephrectomy "mini-nephrectomy" through a posterior transcostal approach
    Surendra Shenoy
    Department of Surgery, Washington University School of Medicine, St Louis, MO, USA
    J Am Coll Surg 194:240-6. 2002
  29. ncbi Variation in plasma leptin concentrations after unilateral nephrectomy
    Mary Ellen Beindorff
    Nutrition Department, Barnes-Jewish Hospital, St Louis, MO 63110, USA
    Metabolism 51:206-10. 2002
    ....
  30. ncbi In vitro T cell proliferation from kidney allograft biopsies with unremarkable pathology: new strategies for an old problem
    Craig R Smith
    Department of Surgery, Washington University School of Medicine, Box 8109-3328.CSRB, 660 South Euclid Avenue, St. Louis, MO 63110-1093, USA
    Transplantation 73:142-5. 2002
    ..Therefore, a subgroup of patients with unremarkable biopsies but T cell proliferation may be at risk for rejection and warrant closer observation and possible tailoring of immunosuppression...